Epigenetic Modifications: Therapeutic Potential in Cancer

Epigenetic Modifications: Therapeutic Potential in Cancer

Epigenetic modifications and alterations in chromatin structure and function contribute to the cumulative changes observed as normal cells undergo malignant transformation. These modifications and enzymes (DNA methyltransferases, histone deacetylases, histone methyltransferases, and demethylases) re...

Bibliografski detalji
Glavni autori:	Manisha Sachan, Manpreet Kaur
Format:	Članak
Jezik:	English
Izdano:	Instituto de Tecnologia do Paraná (Tecpar) 2015-08-01
Serija:	Brazilian Archives of Biology and Technology
Teme:	HDAC inhibitors Cancer epigenetics Histone modification
Online pristup:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132015000400526&lng=en&tlng=en

Slični predmeti

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
od: Michelle Esposito, i dr.
Izdano: (2019-05-01)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
od: Guo Li, i dr.
Izdano: (2020-09-01)

Implication des modifications épigénétiques dans les cancers : développement de nouvelles approches thérapeutiques
od: Willems L., i dr.
Izdano: (2008-01-01)

Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
od: Xiaomin Wang, i dr.
Izdano: (2023-06-01)

Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
od: Delcuve Geneviève P, i dr.
Izdano: (2012-03-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
od: Dineo eKhabele
Izdano: (2014-05-01)

dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation
od: Mohammad Mijanur Rahman, i dr.
Izdano: (2024-12-01)

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
od: Qingfan Yang, i dr.
Izdano: (2022-01-01)

Epigenetic regulation by gut microbiota
od: Vivienne Woo, i dr.
Izdano: (2022-12-01)

Epigenetic modification enzymes: catalytic mechanisms and inhibitors
od: Duo Lu
Izdano: (2013-05-01)

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
od: Dusan Ruzic, i dr.
Izdano: (2022-01-01)

Epigenetic control of the vicious cycle
od: Madeline B. Searcy, i dr.
Izdano: (2024-02-01)

The role of HDAC3 in inflammation: mechanisms and therapeutic implications
od: Noah Watson, i dr.
Izdano: (2024-07-01)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
od: Yu Wang, i dr.
Izdano: (2022-05-01)

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
od: Flavia Lima Costa Faldoni, i dr.
Izdano: (2020-05-01)

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
od: Xilan Yu, i dr.
Izdano: (2018-09-01)

Histones and their modifications in ovarian cancer – drivers of disease and therapeutic targets
od: Deborah Joy Marsh, i dr.
Izdano: (2014-06-01)

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS
od: V. P. Maksimova, i dr.
Izdano: (2020-09-01)

From Bench to Bedside: Targeting Epigenetics for Cancer Therapy
od: Jin-xu Fang, i dr.
Izdano: (2011-12-01)

Mechanisms and technologies in cancer epigenetics
od: Zaki A. Sherif, i dr.
Izdano: (2025-01-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
od: Kelly N. Hassell
Izdano: (2019-11-01)

Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
od: Ibrahim S. Alalhareth, i dr.
Izdano: (2025-02-01)

Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
od: Louis Legoff, i dr.
Izdano: (2021-08-01)

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
od: Hana Q. Sadida, i dr.
Izdano: (2024-01-01)

The proteasome and epigenetics: zooming in on histone modifications
od: Bach Svitlana V., i dr.
Izdano: (2016-08-01)

New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
od: Yi Luan, i dr.
Izdano: (2022-04-01)

Epigenetics modifications and therapeutic prospects in human thyroid cancer
od: Maria Graziella eCatalano, i dr.
Izdano: (2012-03-01)

Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus
od: Xiaojie Wang, i dr.
Izdano: (2012-08-01)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
od: Vera Miranda-Gonçalves, i dr.
Izdano: (2018-10-01)

Connections between metabolism and epigenetic modifications in cancer
od: Wang Guangchao, i dr.
Izdano: (2021-12-01)

Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
od: Wenjing Xiao, i dr.
Izdano: (2021-09-01)

Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
od: Srinivas Patnaik, i dr.
Izdano: (2019-06-01)

Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
od: Maria R. Pozo, i dr.
Izdano: (2022-01-01)

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
od: Vera Miranda-Gonçalves, i dr.
Izdano: (2019-09-01)

Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia
od: Abhinav Dhall, i dr.
Izdano: (2019-05-01)

Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities
od: Reyhaneh Farrokhi Yekta, i dr.
Izdano: (2024-10-01)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
od: Reem Saleh, i dr.
Izdano: (2020-07-01)

Epigenetic Modifications of Host Genes Induced by Bacterial Infection
od: Maryam Parhamfar, i dr.
Izdano: (2021-08-01)

NSD family proteins: Rising stars as therapeutic targets
od: Lin He, i dr.
Izdano: (2024-04-01)

Pulmonary Pathogen-Induced Epigenetic Modifications
od: Dylan Wrede, i dr.
Izdano: (2023-07-01)